Clinical trial
Effect of Early Prescription of Immunosuppressants on First Three-year Course of Crohn's Disease
NCT00546546 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Early Prescription of Immunosuppressants on First Three-year Course of Crohn's Disease
- Lead sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- June 30, 2013
- Enrollment
- 120 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease